Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome

Up to 90% of patients with a myelodysplastic syndrome require red blood cell transfusion; nevertheless, comprehensive data on red cell alloimmunization in such patients are limited. This study evaluates the incidence and clinical impact of red cell alloimmunization in a large cohort of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Deepak, Kutyna, Monika M., Chhetri, Rakchha, Wee, Li Yan A., Hague, Sophia, Nath, Lakshmi, Nath, Shriram V., Sinha, Romi, Wickham, Nicholas, Lewis, Ian D., Ross, David M., Bardy, Peter G., To, Luen Bik, Reynolds, John, Wood, Erica M., Roxby, David J., Hiwase, Devendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709101/
https://www.ncbi.nlm.nih.gov/pubmed/28983058
http://dx.doi.org/10.3324/haematol.2017.175752

Ejemplares similares

Ejemplares similares